DEARBORN PARTNERS LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
DEARBORN PARTNERS LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,442,543
+0.8%
63,249
-0.1%
0.25%
+3.7%
Q2 2023$6,388,410
+10.1%
63,308
+0.4%
0.24%
+7.0%
Q1 2023$5,803,636
+1.4%
63,083
-0.0%
0.23%
-1.3%
Q4 2022$5,723,797
+18.6%
63,093
-0.7%
0.23%
+8.5%
Q3 2022$4,828,000
-10.1%
63,522
-0.0%
0.21%
-6.2%
Q2 2022$5,370,000
-3.7%
63,534
-0.0%
0.23%
+7.1%
Q1 2022$5,578,000
-5.3%
63,560
-5.6%
0.21%
-0.9%
Q4 2021$5,889,000
-20.5%
67,327
-25.6%
0.21%
-28.9%
Q3 2021$7,405,000
-9.6%
90,546
+0.9%
0.30%
-8.5%
Q2 2021$8,190,000
+7.9%
89,765
+1.1%
0.33%
+1.9%
Q1 2021$7,588,000
-10.5%
88,768
-1.2%
0.32%
-16.3%
Q4 2020$8,482,000
+20.7%
89,827
+11.1%
0.39%
+10.3%
Q3 2020$7,028,000
-0.3%
80,825
+0.1%
0.35%
-8.1%
Q2 2020$7,052,000
+8.3%
80,749
+2.3%
0.38%
-5.7%
Q1 2020$6,510,000
-11.2%
78,959
+2.0%
0.40%
+8.3%
Q4 2019$7,333,000
+15.2%
77,441
+5.7%
0.37%
+1.4%
Q3 2019$6,367,000
-5.7%
73,266
-0.9%
0.37%
-10.7%
Q2 2019$6,752,000
-4.1%
73,945
+1.0%
0.41%
-12.3%
Q1 2019$7,040,000
+12.1%
73,228
+0.0%
0.47%
-3.1%
Q4 2018$6,281,000
+0.1%
73,195
+0.5%
0.48%
+10.5%
Q3 2018$6,274,000
+18.5%
72,818
+3.9%
0.44%
+6.0%
Q2 2018$5,294,000
-78.5%
70,081
-77.0%
0.41%
-78.2%
Q1 2018$24,666,000
-21.3%
305,079
-18.2%
1.90%
-15.6%
Q4 2017$31,332,000
-4.4%
373,176
-2.3%
2.26%
-6.5%
Q3 2017$32,781,000
+0.6%
381,838
-2.2%
2.41%
+0.2%
Q2 2017$32,591,000
+18.1%
390,456
+5.1%
2.41%
+12.2%
Q1 2017$27,592,000
+6.5%
371,513
+4.5%
2.15%
-0.9%
Q4 2016$25,900,000
-5.9%
355,580
+2.0%
2.16%
-6.8%
Q3 2016$27,537,000
-2.6%
348,736
+1.8%
2.32%
-5.3%
Q2 2016$28,258,000
+17.5%
342,484
+3.1%
2.45%
+9.6%
Q1 2016$24,055,000
-10.1%
332,057
+6.8%
2.24%
-10.2%
Q4 2015$26,748,000
-1.4%
310,876
+5.3%
2.49%
-8.4%
Q3 2015$27,134,000
-4.2%
295,184
+2.5%
2.72%
-0.4%
Q2 2015$28,314,000
-0.3%
287,920
-0.1%
2.73%
+9.9%
Q1 2015$28,409,000
+19.8%
288,093
+12.6%
2.48%
+14.0%
Q4 2014$23,713,000
-0.5%
255,910
+1.1%
2.18%
-5.5%
Q3 2014$23,828,000
+4.0%
253,142
+0.1%
2.31%
+2.7%
Q2 2014$22,903,000
+14.6%
252,989
+7.6%
2.25%
+3.0%
Q1 2014$19,992,000
+13.5%
235,144
+7.3%
2.18%
+6.1%
Q4 2013$17,616,000
+12.4%
219,156
+7.3%
2.06%
-0.3%
Q3 2013$15,673,000
+14.7%
204,321
+5.7%
2.06%
+6.1%
Q2 2013$13,666,000193,2611.94%
Other shareholders
NOVARTIS A G shareholders Q3 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders